Endobronchial coils for severe emphysema are effective up to 12 months following treatment: Medium term and cross-over results from a randomised controlled trial

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Zoumot, Zaid ^a,b,c   Kemp, Samuel V ^a,b,d   Singh, Suveer ^b   Bicknell, Stephen R ^e   McNulty, William H ^a,b   Hopkinson, Nicholas S ^a   Ross, Ewen T ^e   Shah, Pallav L ^a,b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

^d SHERWOOD FOREST HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE SAFETY; DEVICE THERAPY; DISEASE SEVERITY; EMPHYSEMA; ENDOBRONCHIAL COIL; ESOPHAGUS CANCER; EXERCISE TOLERANCE; FEMALE; FLUOROSCOPY; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; LOWER RESPIRATORY TRACT INFECTION; LUNG PRESSURE; MALE; OUTCOME ASSESSMENT; PNEUMONIA; PNEUMOTHORAX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY THERAPEUTIC DEVICE; THERAPY EFFECT; THORAX PAIN; TREATMENT DURATION; URINARY TRACT INFECTION; AGED; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTHESES AND ORTHOSES; PULMONARY EMPHYSEMA; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; AGED; BRONCHOSCOPY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; PULMONARY EMPHYSEMA; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84928948895     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122656     Document Type: Article

References (24)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. Epub 2012/12/19. doi: 10.1016/ S0140-6736(12)61728-0 PubMed PMID: 23245604.
2. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006; 28(3):523-32. doi: 10.1183/09031936.06. 00124605 PMID: 16611654
3. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest. 2013; 143(5):1395-406. Epub 2013/05/30. 1390070 [pii] doi: 10.1378/chest.12-1135 PubMed PMID: 23715520.
4. National Emphysema Treatment Trial Research Group. A Randomized Trial Comparing Lung-Volume-Reduction Surgery with Medical Therapy for Severe Emphysema. N Engl J Med. 2003; 348(21):2059-73. PMID: 12759479
5. Benzo R, Farrell MH, Chang CCH, Martinez FJ, Kaplan R, Reilly J, et al. Integrating Health Status and Survival Data. American Journal of Respiratory and Critical Care Medicine. 2009; 180(3):239-46. doi: 10.1164/rccm.200809-1383OC PMID: 19483114
6. Clark SJ, Zoumot Z, Bamsey O, Polkey MI, Dusmet M, Lim E, et al. Surgical approaches for lung volume reduction in emphysema. Clin Med. 2014; 14(2):122-7. doi: 10.7861/clinmedicine.14-2-122 PubMed PMID: 24715121.
7. Sciurba FC, Ernst A, Herth FJF, Strange C, Criner GJ, Marquette CH, et al. A Randomized Study of Endobronchial Valves for Advanced Emphysema. New England Journal of Medicine. 2010; 363 (13):1233-44. doi: 10.1056/NEJMoa0900928 PMID: 20860505
8. Herth FJF, Noppen M, Valipour A, Leroy S, Vergnon JM, Ficker JH, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. European Respiratory Journal. 2012; 39 (6):1334-42. doi: 10.1183/09031936.00161611 PMID: 22282552
9. Hopkinson NS, Toma TP, Hansell DM, Goldstraw P, Moxham J, Geddes DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med. 2005; 171(5):453-60. Epub 2004/12/08. doi: 10.1164/rccm.200407-961OC PubMed PMID: 15579725.
10. Hopkinson NS, Kemp SV, Toma TP, Hansell DM, Geddes DM, Shah PL, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011; 37(6):1346-51. Epub 2010/ 10/16. doi: 10.1183/09031936.00100110 PubMed PMID: 20947683.
11. Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O. Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest. 2012; 142(5):1111-7. Epub 2012/06/23. doi: 10.1378/chest.12-0421 PubMed PMID: 22722233.
12. Snell G, Herth FJ, Hopkins P, Baker KM, Witt C, Gotfried MH, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J. 2012; 39(6):1326-33. Epub 2011/11/15. doi: 10.1183/09031936.00092411 09031936.00092411 [pii] PubMed PMID: 22075481.
13. Gompelmann D, Heussel CP, Eberhardt R, Snell G, Hopkins P, Baker K, et al. Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema. Respiration. 2012; 83(5):400-6. Epub 2012/03/02. 000336239 [pii] doi: 10.1159/000336239 PubMed PMID: 22377613.
14. Magnussen H, Kramer MR, Kirsten AM, Marquette C, Valipour A, Stanzel F, et al. Effect of fissure integrity on lung volume reduction using a polymer sealant in advanced emphysema. Thorax. 2012; 67 (4):302-8. Epub 2012/03/01. thoraxjnl-2011-201038 [pii] doi: 10.1136/thoraxjnl-2011-201038 PubMed PMID: 22374920.
15. Shah PL, Slebos DJ, Cardoso PFG, Cetti E, Voelker K, Levine B, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. The Lancet. 2011; 378(9795):997-1005. doi: 10.1016/S0140-6736(11)61050-7 PMID: 21907863
16. Herth FJ, Eberhard R, Gompelmann D, Slebos DJ, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis. 2010; 4(4):225-31. Epub 2010/06/12. 1753465810368553 [pii] doi: 10.1177/1753465810368553 PubMed PMID: 20538661.
17. Slebos DJ, Klooster K, Ernst A, Herth FJF, Kerstjens HAM. Bronchoscopic Lung Volume Reduction Coil treatment of patients with severe heterogeneous emphysema. Chest. 2011. doi: 10.1378/chest.11-0730
18. Shah PL, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quiring J, et al. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med. 2013; 1(3):233-40. Epub 2014/01/17. S2213-2600(13)70047-X [pii] doi: 10.1016/S2213-2600 (13)70047-X PubMed PMID: 24429129.
19. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. The American review of respiratory disease. 1992; 145(6):1321-7 PubMed PMID: 1595997.
20. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD. 2005; 2(1):75-9. Epub 2006/12/02 PubMed PMID: 17136966.
21. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16:5-40 PubMed PMID: 8499054.
22. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med. 2002; 166(1):111-7. PMID: 12091180
23. Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schunemann HJ. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J. 2008; 32(3):637-43. doi: 10. 1183/09031936.00140507 PMID: 18550610
24. O'Donnell DE, Revill SM, Webb KA. Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2001; 164(5):770-7. PMID: 11549531